These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2704099)

  • 21. [Experimental validation of the use of alpha-adrenoblockers in combination with anticoagulants and fibrinolytic agents].
    Kalishevskaia TM; Golubeva MG; Bashkov GV
    Patol Fiziol Eksp Ter; 1988; (3):24-8. PubMed ID: 2902551
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fibrinolytics and defibrinating agents].
    Vergoz D
    Phlebologie; 1975; 28(1):37-8. PubMed ID: 1202531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current status of thrombolysis. The need for coadjuvant antithrombotic therapy].
    García Frade LJ; García Avello A
    Rev Clin Esp; 1993 Jun; 193(2):88-92. PubMed ID: 8341821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic combination of fibrinolytics and vasodilators in cerebral thrombosis].
    Puleo F
    G Gerontol; 1969 Dec; 17(12):1173-8. PubMed ID: 5403490
    [No Abstract]   [Full Text] [Related]  

  • 25. Unusual effects of aspirin on ticlopidine induced thrombolysis.
    Gryglewski RJ; Uracz W; Swieş J
    Thorax; 2000 Oct; 55 Suppl 2(Suppl 2):S17-9. PubMed ID: 10992548
    [No Abstract]   [Full Text] [Related]  

  • 26. Sustained-release of urease from a poloxamer gel matrix.
    Fults KA; Johnston TP
    J Parenter Sci Technol; 1990; 44(2):58-65. PubMed ID: 2338605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current developments in thrombolytic therapy.
    Sherry S
    Thromb Diath Haemorrh Suppl; 1973; 56():201-10. PubMed ID: 4617330
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fibrinolytic substances in thrombosis therapy].
    Stamm H
    Ther Ggw; 1972 Mar; 111(3):335-42. PubMed ID: 4260163
    [No Abstract]   [Full Text] [Related]  

  • 29. [Some recent advances in the anticoagulant and fibrinolytic therapy of thrombosis].
    Samama M
    Angeiologie; 1967; 20():Suppl:54-8. PubMed ID: 5621508
    [No Abstract]   [Full Text] [Related]  

  • 30. Pluronic F-127 gel preparation as an artificial skin in the treatment of third-degree burns in pigs.
    Nalbandian RM; Henry RL; Balko KW; Adams DV; Neuman NR
    J Biomed Mater Res; 1987 Sep; 21(9):1135-48. PubMed ID: 3667639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinolytic guidelines in diabetes.
    Sharma GV; Mukerjee DK; Sasahara AA
    Geriatrics; 1982 Apr; 37(4):38-42, 46. PubMed ID: 7060947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fibrinolytic therapy].
    de Potter E
    Belg Tijdschr Geneesk; 1965 Dec; 21(24):1144-7. PubMed ID: 5847667
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thrombolysis in acute heart infarct].
    Lubsen J; Dunning AJ
    Ned Tijdschr Geneeskd; 1985 Sep; 129(37):1765-8. PubMed ID: 3934566
    [No Abstract]   [Full Text] [Related]  

  • 34. [New agents and challenges in the antithrombotic management of arterial diseases].
    Udvardy M; Rák K
    Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombectomy and thrombolysis--therapeutic alternatives?
    Porter JM; Dotter CT; Rösch J; Goodnight S
    Angiology; 1978 Oct; 29(10):728-40. PubMed ID: 717835
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fibrinolytic therapy].
    Beyer J; Schellong S
    Hamostaseologie; 2005 Nov; 25(4):345-55. PubMed ID: 16395484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fibrinolytic therapy].
    Vreeken J
    Ned Tijdschr Geneeskd; 1985 Sep; 129(36):1720-1. PubMed ID: 3932888
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy and prevention of thromboembolic diseases: anticoagulants and fibrinolytics].
    Pelosio L; Marasco A; Puopolo G
    Clin Ter; 1982 Feb; 100(4):417-25. PubMed ID: 7044661
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic fibrinolysis. What should follow?
    Stead NW
    Circulation; 1991 Aug; 84(2):948-50. PubMed ID: 1860243
    [No Abstract]   [Full Text] [Related]  

  • 40. [On several controversial questions on the use of fibrinolytic preparations in the treatment of thrombosis].
    Mazur NA; Ruda MIa; Kats IA
    Kardiologiia; 1967 Sep; 7(9):35-8. PubMed ID: 4238552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.